In [Figure 1](#pone-0093142-g001){ref-type="fig"}, "Symptoms of Influenza A(H1N1)pdm09 infection in CF, asthmatics and healthy controls," some of the bars are incorrectly shaded. Please see the corrected [Figure 1](#pone-0093142-g001){ref-type="fig"} here.

![Symptoms of Influenza A(H1N1)pdm09 infection in CF, asthmatics and healthy controls.\
Frequency of presenting symptoms in CF patients, asthmatics and healthy controls from four studies of Influenza A(H1N1)pdm09 infection in CF patients \[39\]--\[42\], and a study of asthmatics and healthy controls \[13\] during the 2009 pandemic.](pone.0093142.g001){#pone-0093142-g001}

[Table 1](#pone-0093142-t001){ref-type="table"} has been corrected for improved readability. Please see the corrected [Table 1](#pone-0093142-t001){ref-type="table"} here.
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###### Characteristics, treatment and outcome of Influenza A(H1N1)pdm09-infected CF patients.
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  Country                                    Inf A(H1N1)pdm09 infection in CF patients   Characteristics of CF patients infected with Inf A(H1N1)pdm09 (%)       Treatment (%)                            Outcome (%)                            Conclusion / Recommendation               Ref                                                                                                                                                                                                                                                                                                 
  ----------------------------------------- ------------------------------------------- ------------------------------------------------------------------- ----------------------- ------------------------------------------------------- -------------------------------------- -------------------- ------------ ---------------------------------------------- -------------------------- ----------------------------------------------------------------- -------------------------------------------- -------------------------------------------------------------------------------- --------
                                             ***N*** [1](#nt101){ref-type="table-fn"}               ***Age*** [2](#nt102){ref-type="table-fn"}               ***Incidence\* (%)***   ***P. aerug.*** ***//*** ***B. cepacia coinfection***   ***Pancreatic*** ***Insufficiency***   ***FEV1 pred^3^***   ***Vacc***   ***Oseltamivir*** ***//*** ***Antibiotics***   ***Hospital admission***   ***ICU*** [4](#nt104){ref-type="table-fn"} ***or ventilation***   ***CFR*** [5](#nt105){ref-type="table-fn"}                                                                                   
  Europe[\#](#nt106){ref-type="table-fn"}                       110                                                     13                                           2.3\*                                   n.r.                                             84                            69              8.8                         81 // 66                                48                                            5.4                                                    2.7                                     awareness, infection control, vaccination campaign                 \[39\]
  Italy[\#](#nt106){ref-type="table-fn"}                        68                                                      15                                          53\*\*                                48.5 // 8.8                                        89.7                           53              13.2                        82 // 68                                69                              1.5 ventilation 13.2 on oxygen                                       4.4                                          annual vaccination in adult CF patients                       \[41\]
  Australia                                                     11                                                      22                                           4.4\*                                 100 // 1                                          n.r.                           66             n.av.                       100 // 75                                63                                           n.r.                                                    n.r.                                prompt commencement of oseltamivir and antibiotic therapy              \[42\]
  UK                                                            13                                                      22                                            4\*                                 100 // n.r.                                        n.r.                          51.4             n.r.                       100 // 100                               69                                             0                                                     n.r.                      generally mild illness in CF, potentially more virulent pandemic in the future   \[40\]
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multicenter surveys; \*incidence of Inf A(H1N1)pdm09 infections in CF patients \*\*incidence of Inf A(H1N1)pdm09 infections relating to CF patients with influenza-like illness (ILI); n.r. -- not reported; Vacc -- Vaccination coverage; P. aerug.  =  *Pseudomonas aeruginosa;* B. cepacia * =  Burkholderia cepacia*.
